Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edna Mozes

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Neuroimmunology|December 7, 2010
Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestationsAlona Telerman, Smadar Lapter, Amir Sharabi, et al.
Immunology|December 2, 2008
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine modelsUri Sela, Amir Sharabi, Molly Dayan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretionUri Sela, Rami Hershkoviz, Liora Cahalon, et al.
Plos One|April 5, 2013
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosusZev Sthoeger, Heidy Zinger, Amir Sharabi, et al.
Immunology|July 11, 2006
A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosisBadiga Venkata Aruna, Hava Ben-David, Michael Sela, et al.
Clinical Immunology (Orlando, Fla.)|September 1, 2018
Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1Zev Sthoeger, Amir Sharabi, Heidy Zinger, et al.
Journal of Clinical Immunology|December 29, 2004
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulationDror Luger, Molly Dayan, Heidy Zinger, et al.
Plos One|December 31, 2009
In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in miceArnon Arazi, Amir Sharabi, Heidy Zinger, et al.
Clinical Immunology (Orlando, Fla.)|February 4, 2009
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupusReshmi Parameswaran, Hava Ben David, Amir Sharabi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2006
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-betaAmir Sharabi, Heidy Zinger, Maya Zborowsky, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Neuroimmunology|December 7, 2010
Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestationsAlona Telerman, Smadar Lapter, Amir Sharabi, et al.
Immunology|December 2, 2008
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine modelsUri Sela, Amir Sharabi, Molly Dayan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretionUri Sela, Rami Hershkoviz, Liora Cahalon, et al.
Plos One|April 5, 2013
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosusZev Sthoeger, Heidy Zinger, Amir Sharabi, et al.
Immunology|July 11, 2006
A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosisBadiga Venkata Aruna, Hava Ben-David, Michael Sela, et al.
Clinical Immunology (Orlando, Fla.)|September 1, 2018
Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1Zev Sthoeger, Amir Sharabi, Heidy Zinger, et al.
Journal of Clinical Immunology|December 29, 2004
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulationDror Luger, Molly Dayan, Heidy Zinger, et al.
Plos One|December 31, 2009
In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in miceArnon Arazi, Amir Sharabi, Heidy Zinger, et al.
Clinical Immunology (Orlando, Fla.)|February 4, 2009
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupusReshmi Parameswaran, Hava Ben David, Amir Sharabi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2006
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-betaAmir Sharabi, Heidy Zinger, Maya Zborowsky, et al.
Pageof 6